Cagrilintide is a long-acting amylin analog that works synergistically with GLP-1 agonists for enhanced weight loss results.
How It Works
Amylin is released with insulin after meals. Cagrilintide mimics this effect, reducing appetite and slowing gastric emptying.
Research Benefits
- Enhanced satiety
- Reduced food intake
- Synergy with GLP-1s
- Weekly dosing convenience
Cagrilintide + Semaglutide
The combination (CagriSema) has shown superior weight loss compared to either compound alone.
Research-grade peptides contain only the active ingredient and are NOT equivalent to FDA-approved pharmaceuticals.